Cancer, Colorectal Cancer
Conditions
Keywords
cancer, cancer screening, colorectal cancer, education, rural
Brief summary
The purpose of this study is to help the Dartmouth Cancer Center and the National Cancer Institute understand how to educate people about cancer screening.
Detailed description
The Dartmouth Cancer Center's Community Outreach and Engagement Team will implement Screen to Save 2 using an online format. The education will be based on a set of key messages that cover information about colorectal cancer, including risk factors, prevention, screening recommendations, and screening options. Key messages provided by the National Cancer Institute will be tailored to the local context of NH and VT, including information about local options for getting screened for colorectal cancer. Using online or telephone surveys, some participants will be contacted approximately three months after their initial participation. Some of the participants contacted after three months will again be contacted another three months later (six months after initial participation). The three- and six-month surveys will assess knowledge, attitudes, beliefs, and behaviors related to cancer screening, including outcomes from cancer screening. The primary aim of the study is to implement and evaluate Screen to Save 2 outreach and educational activities to improve knowledge of colorectal cancer screening methods, to increase intent to get screened for colorectal cancer, and connect screening services to the target population.
Interventions
OTHEROnline educational video and website module
Participants will receive online education via a video and website. Key messages will include information on risk factors, prevention, screening recommendations, and screening options pertaining to colorectal cancer. Some participants will be asked to participate in three and/or six-month follow-up surveys administered online or by telephone.
Sponsors
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Dartmouth College
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
45 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
* Resident of one of the RUCC 7-9 counties in New Hampshire or Vermont (Coos or Sullivan County, NH; Caledonia, Windsor, Windham, Orange, Orleans, Lamoille, or Essex County, VT) and * Age 45-74 at the time of enrollment in the study
Exclusion criteria
\- Cognitive impairment preventing participation in informed consent process Three-Month Follow-Up Survey Inclusion Criteria: A participant will be eligible for inclusion in the three-month follow-up survey if the participant completed the pre-test, educational intervention, and post-test and at the time of initial participation: * Answered a colorectal cancer screening history question indicating that the participant has never received colorectal cancer screening OR does not know if he/she has received colorectal cancer screening previously OR * Answered a series of questions indicating that the participant received prior colorectal cancer screening but may be overdue for colorectal cancer screening based on the type of colorectal cancer screening last reported and screening guidelines for the frequency of re-screening. Six-Month Follow-Up Survey Inclusion Criteria: A participant will be eligible for inclusion in the six-month follow-up survey if the participant participated in the three-month-follow up survey and at that time reported that having: * A FIT/FOBT screening or Cologuard (stool) screening performed since the time of initial study participation, but having not received the results * An abnormal FIT/FOBT, or Cologuard (stool) screening since the time of initial study participation, but had not received a diagnostic colonoscopy * A colonoscopy since the time of initial study participation, but had not received the final results
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Correct Responses Regarding Knowledge Related to Colorectal Cancer Risk, Prevention, and Screening | pre-test administered immediately before educational intervention; post-test administered immediately after the educational intervention on day 1. | A pre-test and post-test are conducted with participants to assess changes in knowledge related to key learning outcomes expected from the educational intervention (assessed via 14 true/false and multiple-choice questions, reported as a percent change in points). An increased % change in points represents increased knowledge of each survey question and a value of 0 indicates knowledge did not change (a negative value would indicate decreased knowledge). % change is a unique number that was calculated as the difference between the % answering correctly after the intervention minus the % correct before the intervention; it is representative of the entire data set and not calculated on an individual participant level. P values (\<0.05) are based on chi-square tests. Each row represents a unique survey question evaluating the topic listed in the row title. |
| Change in Colorectal Cancer Screening and Other Risk Behavior Intentions | pre-test administered immediately before educational intervention; post-test administered immediately after educational intervention on day 1 | A pre-test and post-test are conducted to assess behavioral intention related to five prevention and screening behaviors (assessed via 5 questions on a 5-point Likert scale: strongly agree (5), agree, unsure, disagree, strongly disagree(1). The values reported represent the difference between pre-intervention and post-intervention scores, calculated as a unique number for the total responding participants (not calculated individually). A positive change represents increased intent. Each row represents a unique survey question evaluating the topic listed in the row title. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORJudith Rees, BM, BCh, MPH, PhD
Geisel School of Medicine, Dartmouth College
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Customized <55 | 40 Participants |
| Age, Customized 55-59 | 39 Participants |
| Age, Customized 60-64 | 57 Participants |
| Age, Customized 65-69 | 39 Participants |
| Age, Customized 70-74 | 30 Participants |
| Educational attainment College graduate | 155 Participants |
| Educational attainment High school diploma/GED or less | 11 Participants |
| Educational attainment Some college | 39 Participants |
| Ever screened for CRC I don't know | 5 Participants |
| Ever screened for CRC No | 30 Participants |
| Ever screened for CRC Yes | 170 Participants |
| History of CRC No | 200 Participants |
| History of CRC Yes | 5 Participants |
| History of CRC in any distant relatives No | 173 Participants |
| History of CRC in any distant relatives Yes | 32 Participants |
| History of CRC in any first-degree relatives No | 163 Participants |
| History of CRC in any first-degree relatives Yes | 42 Participants |
| History of polyps Data Missing | 19 Participants |
| History of polyps No | 115 Participants |
| History of polyps Yes | 71 Participants |
| Number of Forms of Insurance None | 2 Participants |
| Number of Forms of Insurance Single | 163 Participants |
| Number of Forms of Insurance Two or more | 40 Participants |
| Number of methods of CRC screening Never screened/don't know | 35 Participants |
| Number of methods of CRC screening Single method | 122 Participants |
| Number of methods of CRC screening Two or more methods | 48 Participants |
| Race/Ethnicity, Customized Declined to Answer | 1 Participants |
| Race/Ethnicity, Customized Non-Hispanic White | 202 Participants |
| Race/Ethnicity, Customized Other | 2 Participants |
| Region of Enrollment United States | 205 participants |
| Sex/Gender, Customized Man | 40 Participants |
| Sex/Gender, Customized Non-binary/gender nonconforming | 0 Participants |
| Sex/Gender, Customized Woman | 165 Participants |
| Type of CRC screening method Colonoscopy | 158 Participants |
| Type of CRC screening method Computed Tomography | 1 Participants |
| Type of CRC screening method DNA (Cologuard) | 21 Participants |
| Type of CRC screening method FIT/FOBT | 25 Participants |
| Type of CRC screening method Sigmoidoscopy | 20 Participants |
| Type of insurance Current or former employer | 112 Participants |
| Type of insurance Individual plan | 21 Participants |
| Type of insurance Medicaid | 12 Participants |
| Type of insurance Medicare | 75 Participants |
| Type of insurance Military | 8 Participants |
| Type of insurance Other | 18 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 205 |
| other Total, other adverse events | 0 / 205 |
| serious Total, serious adverse events | 0 / 205 |
Outcome results
None listed